The U.S. Food and Drug Administration (FDA) has announced an ambitious effort to modernize drug testing by reducing reliance ...

Though research on sexual experience in nonhuman animals is limited to primates and rodents, there's reason to think that ...

The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

Humans typically consider peeing a private act. But for many animals, it’s a crucial way to share information —one that goes ...

The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...

FDA Commissioner Martin Makary said this move would offer newer treatments for patients quicker, while also reducing the cost of research and development. Other news includes: lab models of pain ...

Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their ...

Studying the early development of human embryos is challenging due to ethical constraints and technical difficulties.